Immunology of Infectious Disease News Volume 11.40 | Oct 11 2023

    0
    11







    2023-10-11 | IIDN 11.40


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 11.40 – 11 October, 2023
    TOP STORY

    Novel Function of MOTS-C in Mitochondrial Remodeling Contributes to Its Antiviral Role During HBV Infection

    Scientists explored the diagnostic and therapeutic potential of MOTS-c in hepatitis B virus-related diseases and its molecular mechanism.
    [Gut]

    Abstract
    quarterly-travel-award
    PUBLICATIONSRanked by the impact factor of the journal

    Complement Factor D Targeting Protects Endotheliopathy in Organoid and Monkey Models of COVID-19

    Researchers developed an infection-competent human vascular organoid from pluripotent stem cells for modeling endotheliopathy. Longitudinal serum proteome analysis identified aberrant complement signature in critically ill patients driven by the amplification cycle regulated by complement factor B and D.
    [Cell Stem Cell]

    Full ArticlePress ReleaseGraphical Abstract

    A Randomised Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study)

    The “Indoor Transmission of COVID-19” trial aimed to assess the risk of transmission of SARS-CoV-2 and other respiratory viruses during an indoor clubbing event among participants fully-vaccinated against COVID-19.
    [Clinical Infectious Diseases]

    Abstract

    High-Resolution Structure of Stem-Loop 4 from the 5′-UTR of SARS-CoV-2 Solved by Solution State NMR

    Investigators presented the high-resolution structure of stem-loop 4 of the 5′-untranslated region (UTR) of the SARS-CoV-2 genome solved by solution-state nuclear magnetic resonance spectroscopy.
    [Nucleic Acids Research]

    Full Article
    Graphical Abstract

    A Next-Generation Intranasal Trivalent MMS Vaccine Induces Durable and Broad Protection Against SARS-CoV-2 Variants of Concern

    By expressing the six-proline-stabilized prefusion spikes from three diverse SARS-CoV-2 strains in the MeV, MuV-JL1, and MuV-JL2 vaccine strains from MMR, researchers generated a MMS trivalent vaccine candidate.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    Cross-Protection and Cross-Neutralization Capacity of Ancestral and VOC-Matched SARS-CoV-2 Adenoviral Vector-Based Vaccines

    Investigators used preclinical rodent models to establish the cross-protective and cross-neutralizing capacity of adenoviral-vectored vaccines expressing variants of concern-matched spike.
    [NPJ Vaccines]

    Full Article

    The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial

    This phase II, multi-center, double-blinded, randomized controlled trial compared high-dose trivalent influenza vaccine to standard-dose quadrivalent influenza vaccine in children 3–17 years old who were 3–35 months post-allogeneic hematopoietic cell transplant.
    [Clinical Infectious Diseases]

    Full Article

    Creating Resistance to Avian Influenza Infection through Genome Editing of the ANP32 Gene Family

    Scientists used CRISPR/Cas9 to generate homozygous gene edited chickens containing two ANP32A amino acid substitutions that prevented viral polymerase interaction.
    [Nature Communications]

    Full Article

    Isolated Nocturnal Hypertension in People Living with Human Immunodeficiency Virus: A Cross-Sectional Study

    Researchers documented the prevalence of nocturnal hypertension and isolated nocturnal hypertension and the clinical factors associated with these phenotypes.
    [American Journal Of Hypertension]

    AbstractGraphical Abstract
    ON831CC_645x110-ebook
    REVIEW

    The Immune Response to SARS-CoV-2 in People with HIV

    The authors examine the intersection of the HIV and SARS-CoV-2 pandemics. People with HIV are a heterogeneous group that differ in their degree of immune suppression, immune reconstitution, and viral control.
    [Cellular & Molecular Immunology]

    Full Article

    Profiles of Gut Microbiota Associated with Clinical Outcomes in Patients with Different Stages of SARS-CoV-2 Infection

    This review of both in vivo and clinical studies has revealed a consistent decline in alpha diversity and increased dissimilarity in beta diversity of gut microbiota in comparison to healthy populations, observed during both the acute and post-infection phases of COVID-19.
    [Life Sciences]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Nipah Virus Is Deadly — But Smart Policy Changes Can Help Quell Pandemic Risk

    Nipah, a deadly RNA virus that can spill over from bats to humans, has infected six people and killed two in the Indian state of Kerala since August. The virus can cause encephalitis — inflammation of the brain — which manifests as fever, headaches, vomiting and respiratory distress.
    [Nature]

    News Article

    Second Malaria Vaccine to Win Global Approval Is Cheaper and Easier to Make

    The World Health Organization has endorsed a second malaria vaccine to protect children against the deadly disease, which killed 619,000 people in 2021. Researchers say that the vaccine, known as R21, is easier to make than the first-approved malaria vaccine, called RTS,S, and will be cheaper per dose.
    [Nature]

    News Article
    FEATURED EVENT

    AACR-KCA Joint Conference on Precision Medicine in Cancer

    November 15 – 17, 2023
    Seoul, Korea

    > See All Events

    JOB OPPORTUNITIES

    Clinical Research Data Analyst – Infectious Diseases

    University of Washington – Medical Lake, Washington, United States

    Assistant/Associate Professor – Infectious Disease

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Research Opportunities – Pediatrics Infectious Diseases

    University of Washington – Medical Lake, Washington, United States

    Postdoctoral Position – Mucosal Immunity

    Stanford University – Stanford, California, United States

    Postdoctoral Associate – NMR-based Metabolomics and Metabolomic Imaging

    Massachusetts General Hospital – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter